Loading...
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their recovery in different immune compartments is largely unknown. Here, we studied how anti-CD20 treatment influenc...
Na minha lista:
| Udgivet i: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166805/ https://ncbi.nlm.nih.gov/pubmed/30194232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1810470115 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|